“Foundayo is a daily oral tablet that can be taken without food, water or timing restrictions”
Medical Director
| Foundayo dose | Price |
|---|---|
| 0.8mg | £59.99 was £100.00 |
| 2.5mg | £119.00 |
| 5.5mg | £139.00 |
| 9mg | £159.00 |
| 14.5mg | £179.00 |
| 17.2mg | £199.00 |
At checkout, choose to get your treatment dispensed automatically, or to pay as you go.
Answer a few questions about your health and confirm your ID. Our UK-based clinicians only prescribe if treatment is right for you.
Your treatment arrives in discreet packaging with clear instructions. Video guides walk you through your first dose.
In weeks 2 to 4 people often notice changes in appetite, like feeling fuller sooner. We’ll check in regularly to see how you’re doing.
After 2 to 6 months people often notice changes in weight, habits and how clothes fit. Progress looks different for everyone, but consistency adds up.
Like all medications, GLP-1s can cause side effects. The good news is they’re usually mild and manageable.
Our UK-based prescribers make the final decision, based on your consultation answers.
This would be outside the medication’s licensed use, which is known as off-label prescribing. Our clinicians assess if treatment is appropriate for you based on your individual circumstances.
Treatment may be appropriate for you if you have a weight-related health condition such as type 2 diabetes, high blood pressure, sleep apnoea or high cholesterol.
This is the standard BMI threshold for weight management treatment. You don’t need to have another weight-related health condition
*Your ethnicity and other health and medical factors are also considered.
We’ll check your medical history during your online consultation to make sure treatment is safe for you.
Our team of over 500 UK-based clinicians have helped more than 2.3 million people since 2013.
You won’t be alone. Our clinical and support teams are here whenever you need us.
Stopping medication once you’ve reached your goal can feel daunting. Our clinicians will talk you through your options and agree the next steps with you.
The MedExpress companion app is here to simplify your weight loss journey. You can use it to track your progress, set reminders, and get support for side effects or chat with our team.
Price from £139.99 was £179.99 | Price from £69.99 was £99.99 | Price from £59.99 was £100.00 | Price from £59.99 was £100.00 |
Avg. weight loss 22.5% in 72 weeks1 at the highest dose | Avg. weight loss 20.7% in 72 weeks2 at the highest dose | Avg. weight loss 16.6% in 64 weeks3 at the highest dose | Avg. weight loss 12.4% in 72 weeks4 at the highest dose |
Format Injection | Format Injection | Format Oral tablet | Format Oral tablet |
Foundayo and Wegovy are both GLP-1 weight loss treatments, but they aren’t the same medication. Foundayo contains orforglipron, while Wegovy contains semaglutide. Both are available as pills, but unlike the Wegovy® Pill, Foundayo can be taken at any time of day, with or without food, and doesn’t require fasting before or after taking it.
Clinical studies suggest the Wegovy® Pill may lead to greater average weight loss, while Foundayo offers a more flexible dosing routine. Your clinician can help you decide which treatment best suits your lifestyle and weight loss goals.
Foundayo and Mounjaro are different types of weight loss medication. Foundayo is a once-daily GLP-1 tablet containing orforglipron, while Mounjaro is a once-weekly injection containing tirzepatide, which targets both the GLP-1 and GIP receptors.
Clinical studies suggest Mounjaro produces greater average weight loss than Foundayo. However, Foundayo may appeal to people who would prefer an oral treatment that can be taken without injections, fasting or strict timing requirements. Your clinician can help you choose the treatment that’s right for you.
Yes, it may be possible to switch from an injectable weight loss treatment to Foundayo, but this should always be done under the guidance of your clinician. Your clinician will consider factors such as your current medication, how well it’s working, any side effects you’re experiencing and your weight loss goals before recommending a switch.
For some people, Foundayo may offer a more convenient alternative to injections, while others may benefit from staying on their current treatment. Your treatment plan should always be personalised to your individual needs.
Dr. Adam Abbs is Medical Director at MedExpress. He has extensive experience in asynchronous and video consultations, technology-enabled remote examinations and home biomarker testing, with a particular interest in educating both patients and doctors. Adam is a published author and is licensed to practice medicine in the UK and across the EU. He’s also registered in Canada.
Dr. Carla Rodrigues is Head of Medical Operations at MedExpress, having previously held leadership roles in primary care networks and across well-known healthcare organisations. She’s led scientific society groups in the field of sexual medicine, and has also completed training with MIT, Harvard and INSEAD. Here, Carla leads medical operations in the UK, overseeing the delivery of safe care pathways and upholding high standards in prescribing and clinical governance.
Dr. Kavir Matharu is GP Lead at MedExpress, with 10 years’ experience across a range of healthcare settings. She is a practising GP with a background in complex healthcare consulting, having worked on high-level strategic and operational challenges within the health system. She was also selected for a leadership fellowship with the National Medical Director at NHS England. Kavir has a strong interest in healthcare leadership and system improvement, with a focus on high-quality, sustainable care.
Dr. Daryl Perera is GP Lead at MedExpress, with experience across NHS primary care, urgent care and private practice. He has extensive experience in digital healthcare and clinical leadership, and oversees clinical governance and patient safety across our digital health services. His work spans urgent care and preventative medicine, with particular interests in men’s health, obesity management, and sport and exercise medicine. Daryl has worked across a range of NHS and private healthcare organisations and previously held a GP Director role.
Head of Medical Affairs
BSc (Hons), MSc, PhD
Dr. Sophie Dix is Head of Medical Affairs at MedExpress, and a behavioural neuroscientist with over 25 years’ experience across the pharmaceutical industry, charity sector and health technology. Her work has focused on understanding how to manage and treat conditions affecting both mind and body, bringing together scientific insight with real-world care. Sophie is passionate about evidence and ensuring people have access to the right treatment at the right time.
Medical Writer
BSc (Hons), MSc, PhD
Dr. Zoe Lees is a Medical Writer at MedExpress, specialising in clear, evidence-based health communications. She completed her postgraduate research at the University of Glasgow, focusing on metabolic complications of pregnancy and the role of adipose tissue function. Zoe brings a strong scientific foundation to her work and is committed to delivering content that is both accurate and accessible, grounded in robust research.
Liyya Patel is Deputy Chief Pharmacist at MedExpress UK, with over 13 years’ experience supporting the organisation’s growth and development. She is responsible for ensuring pharmacy services are safe, compliant and meet all regulatory standards, playing a key role in maintaining high-quality clinical care.
Dr. Olivia de Rougemont is GP Lead at MedExpress, with over 14 years’ experience across the NHS and private sectors. She has extensive experience in digital and in-person care, with a particular interest in women’s health, preventative medicine, and delivering patient-centred support that feels clear and accessible. Olivia also leads and mentors GPs, and brings a global perspective shaped by her experience working across different healthcare systems.
Dr. Karuna is GP Lead at MedExpress. She brings a broad portfolio of experience in NHS primary care, including general practice, NHS 111, and urgent care services. She has extensive expertise in digital healthcare, providing remote consultations to both NHS and private patients, and previously held a senior leadership role in a large scale digital-first healthcare platform.
Found it cheaper? We’ll match it.*
As you progress, we’ll support you in changing your dose or treatment.
Over 500 UK-registered clinicians for support whenever you need it.
Get your orders dispensed automatically, or choose to pay-as-you-go.
*Price match applies to providers listed in the terms and conditions
SURMOUNT-1, 72-week study of adults with obesity using Mounjaro (tirzepatide 15mg). Individual results vary.
STEP UP, 72-week study of adults with obesity using Wegovy (semaglutide 7.2mg). Individual results vary.
OASIS 4, 64-week study of adults with obesity using oral semaglutide 25mg alongside lifestyle changes. Individual results vary.
ATTAIN-1, 72-week study of adults with obesity using the maximum dose of orforglipron alongside lifestyle changes. Individual results vary.
Discreet packaging
UK-registered pharmacy
No waiting rooms
Fast delivery
24/7 support
Price match
Trusted by 2.3m+ people
57k reviews
No lock-in contracts
